Sara Lodi, PhD
Associate Professor
Boston University School of Public Health
Biostatistics

PhD, London School of Hygiene & Tropical Medicine
MSc, University of Southampton
BA, Univ of Bologna

Pronouns: she/her/hers



Sara Lodi is an Associate Professor of Biostatistics at the Boston University School of Public Heath. She obtained her PhD in Medical Statistics at the London School of Hygiene and Tropical Medicine in 2009, UK. Her research focuses on causal inference methods for observational studies using big data, methods for causal inference to improve the statistical analysis of clinical trials, and the reconciliation of results from clinical trials and observational studies. She leads cutting edge research that focuses on the translation of methodologic advancements in causal inference into actionable findings for real world public health research questions, mainly in the areas of infectious diseases (HIV, hepatitis C, tuberculosis) and substance use disorder. She has published many articles on behalf of large international collaborations of HIV cohorts such as CASCADE, COHERE and the HIV-CAUSAL, and HepCAUSAL collaborations. She’s been an instructor for both BS851 Applied Statistics in Clinical Trials and BS807 Applied Causal Inference in Health Research.

Diversity, Equity, Inclusion and Accessibility

I have incorporated DEIJ into my activities in multiple ways:
-I have participated in University-wide DEIJ training
-I have completed additional DEIJ training for search committees
-I participate in discussions of DEIJ topics that arise at each department faculty meeting
-I collaborate with a diverse group of investigators with a range of backgrounds and cultures
-I teach and mentor a diverse group of students and trainees
-I completed the title IX mandatory training


Dynamic Strategies for the clinical management of HIV disease
06/01/2023 - 05/31/2028 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health NIH NIAID


Personnel Agreement for Research Services of Sara Lodi
06/01/2022 - 05/31/2025 (PI)
Ann Arbor VA Medical Center


VA CAUSAL
09/30/2023 - 09/29/2024 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health VA Maine Healthcare


MOUD Comparative Effectiveness Study
07/01/2021 - 04/30/2024 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
5R01DA054268-03

VA CAUSAL
04/01/2023 - 09/29/2023 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health Department of VA


Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers - 1/2
09/15/2017 - 08/31/2023 (Subcontract PI)
The Regents of the University of California, San Francisco NIH NIAAA
5U01AA026223-06

Dynamic Strategies for the clinical management of HIV disease
06/01/2020 - 05/31/2023 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health NIH NIAID
5R37AI102634-10

Population-Level Effects of Increasing PrEP Uptake on HIV and Bacterial STIs
07/26/2019 - 06/30/2022 (Subcontract PI)
Harvard Pilgrim Health Care Inc NIH NIAID
1R21Al143386-01A1

Causal inference for the treatment and management of multidrug-resistant tuberculosis
12/01/2020 - 08/31/2021 (Key Person / Mentor)
NIH/National Institute of Allergy & Infectious Diseases
1F31AI157333-01

Stigma, Risk Behaviors and Health care among HIV-Infected Russian People Who Inject Drugs
09/01/2020 - 08/31/2021 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
5R00DA041245-05

Showing 10 of 12 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Weinstein ZM, Magane KM, Lodi S, Ventura AS, Bazzi AR, Blodgett J, Fielman S, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R. The Impact of COVID-19 on Substance Use and Related Consequences among Patients in Office-Based Opioid Use Disorder Treatment. J Addict Med. 2024 Aug 05.View Related Profiles. PMID: 39101572
     
  2. Idrisov B, Van Draanen J, Lodi S, Lunze K, Kimmel SD, Quinn EK, Truong V, Blokhina E, Gnatienko N, Krupitsky E, Samet JH, Williams EC. Socioeconomic Status and CD4 Count Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS Behav. 2024 Jul; 28(7):2239-2246.View Related Profiles. PMID: 38658481; DOI: 10.1007/s10461-024-04316-z;
     
  3. Christine PJ, Lodi S, Hsu HE, Bovell-Ammon B, Yan S, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz J, Walley AY, Larochelle MR. Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder. Addiction. 2024 Jul; 119(7):1313-1321.View Related Profiles. PMID: 38519819; PMCID: PMC11156545; DOI: 10.1111/add.16473;
     
  4. Tumwegamire A, Fatch R, Emenyonu NI, Lodi S, Muyindike WR, Kekibiina A, Adong J, Ngabirano C, Beesiga B, Marson K, Golabi N, Kamya M, Chamie G, Hahn JA. Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda. PLoS One. 2024; 19(3):e0300508. PMID: 38507431; PMCID: PMC10954112; DOI: 10.1371/journal.pone.0300508;
     
  5. Sewak A, Lodi S, Li X, Shu D, Wen L, Mayer KH, Krakower DS, Young JG, Marcus JL. Causal Effects of Stochastic PrEP Interventions on HIV Incidence Among Men Who Have Sex With Men. Am J Epidemiol. 2024 Jan 08; 193(1):6-16. PMID: 37073419; PMCID: PMC10773485; DOI: 10.1093/aje/kwad097;
     
  6. Chamie G, Hahn JA, Kekibiina A, Emenyonu NI, Beesiga B, Marson K, Fatch R, Lodi S, Adong J, Thirumurthy H, McDonell MG, Gandhi M, Bryant K, Havlir DV, Kamya MR, Muyindike WR. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial. Lancet Glob Health. 2023 Dec; 11(12):e1899-e1910. PMID: 37973340; PMCID: PMC11005200; DOI: 10.1016/S2214-109X(23)00436-9;
     
  7. McLaughlin A, Lin N, Jiang W, Lodi S, Lioznov D, Patts G, Gnatienko N, Blokhina E, Bendiks S, Freiberg MS, Tindle HA, Krupitsky E, Hahn JA, Samet JH, So-Armah K. Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia. J Acquir Immune Defic Syndr. 2023 Nov 01; 94(3):244-252.View Related Profiles. PMID: 37850982; PMCID: PMC10593489; DOI: 10.1097/QAI.0000000000003250;
     
  8. Rein SM, Lodi S, Logan RW, Touloumi G, Antoniadou A, Wittkop L, Bonnet F, van Sighem A, van der Valk M, Reiss P, Klein MB, Young J, Jarrin I, d'Arminio Monforte A, Tavelli A, Meyer L, Tran L, Gill MJ, Lang R, Surial B, Haas AD, Justice AC, Rentsch CT, Phillips A, Sabin CA, Miro JM, Trickey A, Ingle SM, Sterne JAC, Hernán MA. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration. Lancet HIV. 2023 Nov; 10(11):e723-e732. PMID: 37923486; PMCID: PMC10695103; DOI: 10.1016/S2352-3018(23)00233-3;
     
  9. Hansford HJ, Cashin AG, Jones MD, Swanson SA, Islam N, Dahabreh IJ, Dickerman BA, Egger M, Garcia-Albeniz X, Golub RM, Lodi S, Moreno-Betancur M, Pearson SA, Schneeweiss S, Sterne J, Sharp MK, Stuart EA, Hernan MA, Lee H, McAuley JH. Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline. BMJ Open. 2023 Sep 12; 13(9):e074626. PMID: 37699620; PMCID: PMC10503363; DOI: 10.1136/bmjopen-2023-074626;
     
  10. Hansford HJ, Cashin AG, Jones MD, Swanson SA, Islam N, Douglas SRG, Rizzo RRN, Devonshire JJ, Williams SA, Dahabreh IJ, Dickerman BA, Egger M, Garcia-Albeniz X, Golub RM, Lodi S, Moreno-Betancur M, Pearson SA, Schneeweiss S, Sterne JAC, Sharp MK, Stuart EA, Hernán MA, Lee H, McAuley JH. Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review. JAMA Netw Open. 2023 Sep 05; 6(9):e2336023. PMID: 37755828; PMCID: PMC10534275; DOI: 10.1001/jamanetworkopen.2023.36023;
     
Showing 10 of 89 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 89 publications over 16 distinct years, with a maximum of 20 publications in 2022

YearPublications
20041
20104
20114
20125
20134
20146
20151
20163
20173
20182
20193
20203
202115
202220
202310
20245

Note: Tweets will show if you have logged into X.com. Otherwise you will see a message that there is nothing to see yet.

Projected Long-Term Impact of the COVID-19 Pandemic on Outcomes Associated With Hepatitis C Virus

Infection Disease Advisor 10/7/2021
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

HIV
Causal inference
Clinical trials
Hepatitis C
Substance Use Disorder
Contact for Mentoring:

801 Massachusetts Avenue
Boston MA 02118
Google Map

617.638.5160
Download vCard

Lodi's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (227) concept(s)
_
Media Mentions
_
Co-Authors
See all (44) people
_
Similar People
See all (60) people
_
Same Department
Search Department